- Home
- GCT vs OCS Comparison
GCT vs OCS Comparison
Compare GCT & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCT
- OCS
- Stock Information
- Founded
- GCT 2019
- OCS 2003
- Country
- GCT United States
- OCS Switzerland
- Employees
- GCT N/A
- OCS N/A
- Industry
- GCT Catalog/Specialty Distribution
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- GCT Consumer Discretionary
- OCS Health Care
- Exchange
- GCT Nasdaq
- OCS Nasdaq
- Market Cap
- GCT 734.6M
- OCS 689.8M
- IPO Year
- GCT 2022
- OCS N/A
- Fundamental
- Price
- GCT $12.73
- OCS $18.27
- Analyst Decision
- GCT Strong Buy
- OCS Strong Buy
- Analyst Count
- GCT 3
- OCS 4
- Target Price
- GCT $36.67
- OCS $30.25
- AVG Volume (30 Days)
- GCT 1.1M
- OCS 48.2K
- Earning Date
- GCT 05-08-2025
- OCS 05-07-2025
- Dividend Yield
- GCT N/A
- OCS N/A
- EPS Growth
- GCT 32.61
- OCS N/A
- EPS
- GCT 3.05
- OCS N/A
- Revenue
- GCT $1,161,042,000.00
- OCS $757,024.00
- Revenue This Year
- GCT $3.01
- OCS $57.00
- Revenue Next Year
- GCT $6.52
- OCS $1,820.89
- P/E Ratio
- GCT $4.17
- OCS N/A
- Revenue Growth
- GCT 64.96
- OCS N/A
- 52 Week Low
- GCT $11.17
- OCS $10.79
- 52 Week High
- GCT $41.31
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- GCT 41.82
- OCS 52.53
- Support Level
- GCT $11.77
- OCS $14.00
- Resistance Level
- GCT $13.67
- OCS $16.39
- Average True Range (ATR)
- GCT 1.00
- OCS 0.94
- MACD
- GCT 0.02
- OCS 0.22
- Stochastic Oscillator
- GCT 42.16
- OCS 71.40
About GCT GigaCloud Technology Inc
GigaCloud Technology Inc end-to-end B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.